Roadside Impairment Detection and Field Sobriety Testing Technologies Market Survey, 55988-55989 [2019-22727]

Download as PDF 55988 Federal Register / Vol. 84, No. 202 / Friday, October 18, 2019 / Notices DEPARTMENT OF JUSTICE To submit comments: Send them to: By mail ......... Assistant Attorney General, U.S. DOJ—ENRD, P.O. Box 7611, Washington, DC 20044–7611. Office of Justice Programs As provided by RCRA, a public meeting will be held on the proposed settlement if requested in writing by fifteen (15) days after the publication date of this notice. Requests for a public meeting may be made by contacting the EPA Remedial Project Manager for OU2, Julie Sullivan, by email at sullivan.julie@epa.gov. If a public meeting is requested, information about the date and time of the meeting will be published in the local newspaper, The Whittier Daily, and will be sent to persons on the EPA Omega Superfund Site mailing list. During the public comment period, the lodged proposed Amendment 2 and the previously approved Consent Decree may be examined and downloaded at this Justice Department website: https:// www.usdoj.gov/enrd/consent-decrees. We will provide a paper copy of the Consent Decree and the proposed Amendment upon written request and payment of reproduction costs. Please mail your request and payment to: Consent Decree Library, U.S. DOJ— ENRD, P.O. Box 7611, Washington, DC 20044–7611. Please enclose a check or money order for $90.25 (25 cents per page reproduction cost) payable to the United States Treasury, for a paper copy of the initial Consent Decree, the previous Amendment 1, and the proposed Amendment 2. For a paper copy of the initial Consent Decree, the previous Amendment 1, and the proposed Amendment 2 without the appendices and signature pages to the initial Consent Decree, the cost is $25.25. For a paper copy of Amendment 2 only (without the initial Consent Decree or Amendment 1), together with its signature pages, the cost is $2.00. Henry S. Friedman, Assistant Section Chief, Environmental Enforcement Section, Environment and Natural Resources Division. [FR Doc. 2019–22739 Filed 10–17–19; 8:45 am] BILLING CODE 4410–15–P VerDate Sep<11>2014 16:37 Oct 17, 2019 Jkt 250001 [OJP (NIJ) Docket No. 1768] Roadside Impairment Detection and Field Sobriety Testing Technologies Market Survey National Institute of Justice (NIJ), Justice. ACTION: Notice of request for information. AGENCY: The National Institute of Justice (NIJ) is soliciting information for use in an upcoming Criminal Justice Testing and Evaluation Consortium (CJTEC) report tentatively titled, ‘‘A Landscape Report of Roadside Impairment Detection and Field Sobriety Testing Technologies.’’ The report will identify technologies that are commercially available or near-market technologies to determine impairment of an individual in a field setting. This document will assist law enforcement agencies in making informed decisions for purchasing impairment technologies to determine whether an individual is driving while impaired or under the influence of drugs. DATES: Emailed responses must be received (and mailed responses postmarked) by 5:00 p.m. Eastern Time on December 2, 2019. ADDRESSES: Responses to this request may be submitted electronically by email to Marjorie Baldi at mbaldi@ rti.org with the subject line ‘‘Impairment Detection Technologies Federal Register Response.’’ Responses may also be sent by mail to the following address: Criminal Justice Testing and Evaluation Consortium (CJTEC), ATTN: Marjorie Baldi, Impairment Detection Technologies Federal Register Response, RTI International, P.O. Box 12194, 3040 E Cornwallis Road, Research Triangle Park, NC 27709–2194. FOR FURTHER INFORMATION CONTACT: For more information on this market survey, please contact Rebecca Shute (CJTEC) by telephone at 919–248–4218 or rshute@rti.org. For more information on the NIJ CJTEC, visit https://nij.ojp.gov/ funding/awards/2018-75-cx-k003 and view the description, or contact Steven Schuetz (NIJ) by telephone at 202–514– 7663 or at steven.schuetz@usdoj.gov. Please note that these are not toll-free telephone numbers. SUPPLEMENTARY INFORMATION: Information sought: Specific product and company information for: (1) Technologies that can help law enforcement officers determine that a certain level of intoxicant is present in SUMMARY: PO 00000 Frm 00087 Fmt 4703 Sfmt 4703 an individual’s system at a specific cutoff concentration, and (2) technologies that help law enforcement officers establish whether an individual is impaired, including eye tracking technologies, physical coordination sensors and apps, and mental agility apps. An independent response should be submitted for each product that respondents would like CJTEC to consider in their landscape report. NIJ encourages respondents to provide information in common file formats, such as Microsoft Word, pdf, or plain text. Each response should include contact information. Usage: Information provided in response to this request may be published in the upcoming landscape report, ‘‘A Landscape Study of Roadside Impairment Detection and Field Sobriety Testing Technologies.’’ Information categories: Comments are invited with regard to the market survey, including which categories of information are appropriate for comparison, as well as promotional material (e.g., slick sheet) and printquality photographs of the technology. At a minimum, CJTEC intends to include the following categories of information for each technology that may be of use to law enforcement officials: 1. Vendor Information a. Full name of company b. Contact information for technical contact for products c. Website URL d. Years the company has been in business e. Number and types of customers served (e.g., municipal, county, or state agencies) f. Location where the technologies are manufactured, assembled, refurbished g. Picture or photograph of product h. Vendor logo 2. Product Information a. Device Category i. Technologies that determine that a certain level of intoxicant is present in an individual’s system at a specific cutoff concentration (this includes products that detect the presence of drugs in breath, oral fluid, sweat or other matrices) ii. Technologies that establish whether an individual is impaired, including eye tracking technologies, physical coordination sensors and apps, and mental agility apps. b. Physical Information i. Dimensions (in inches) ii. Weight (in pounds) iii. Primary materials used to construct the product E:\FR\FM\18OCN1.SGM 18OCN1 Federal Register / Vol. 84, No. 202 / Friday, October 18, 2019 / Notices iv. Temperature range in which the product can reliably operate (in Fahrenheit and Celsius) v. Display unit (e.g., diagonal size of screen in inches as well as type of screen) vi. Ruggedization (including features that optimize the product for field use, such as waterproofing, and any corresponding standards compliance) c. Technical Specifications i. Type of sensor or test used to determine impairment or intoxication ii. Detection range of sensor or test (e.g., g/L) iii. Cut-off concentration for each drug tested (ng/mL) iv. Accuracy of the instrument (e.g., standard error, false positive and false negative rate) v. Memory capability of instrument (either in MB/GB or number of tests stored) vi. Whether test records and other data on the instrument can be transferred, and the method by which it is transferred (e.g., internet connectivity, ethernet cables, Bluetooth connectivity) vii. Power supply (e.g. battery or voltage of power supply) viii. Battery life, if applicable ix. Standard accessories offered d. Types/Classes of Drugs Detected i. Alcohol ii. Opioids iii. Benzodiazepines iv. Cannabinoids v. Barbiturates vi. Cocaine vii. Amphetamines viii. Methamphetamines ix. Ketamine x. Other e. Operating Information of Device/ Hardware i. Calibration requirements for device, if applicable (e.g., how it is calibrated, how long it takes, frequency of calibration) ii. Average response time of test (in minutes) iii. Warm-up time of device (in minutes) iv. Training offered and cost v. Technical support offered and cost vi. Other maintenance required for instrument vii. Terms and cost of any standard and/or extended warranties offered f. Software (if applicable) i. Frequency of software updates ii. Last known software release date iii. Steps needed to update software iv. Operating System required for use v. Other system requirements for use (e.g., hardware requirements or VerDate Sep<11>2014 16:37 Oct 17, 2019 Jkt 250001 supporting software packages) vi. Use of web servers or cloud storage by software vii. Licenses required to use the software g. Financial Information i. Base unit cost (in USD) ii. Software costs (including whether it is a subscription service, license, or other, in USD) iii. Other associated costs (in USD) iv. Accessory Costs (in USD) v. Training Costs (in USD) vi. Financing Options (e.g., lease versus ownership) h. Other information 3. Use Cases a. Approximate number of units sold to law enforcement (if available) b. Names and contact information (phone and email) for end users who have implemented the product in casework (if available) David B. Muhlhausen, Director, National Institute of Justice. [FR Doc. 2019–22727 Filed 10–17–19; 8:45 am] BILLING CODE 4410–18–P JUSTICE DEPARTMENT National Institute of Corrections Charter Re-Establishment for the National Institute of Corrections Advisory Board Re-establishment of Federal Advisory Committee. ACTION: Under the provisions of the Federal Advisory Committee Act of 1972 (FACA) and the Government in the Sunshine Act of 1976, the National Institute of Corrections (NIC) gives notice that it is re-establishing the charter for the National Institute of Corrections Advisory Board (hereafter referred to as ‘‘the Board’’). FOR FURTHER INFORMATION CONTACT: Shaina Vanek, Advisory Board Designated Federal Officer for the National Institute of Corrections, 202– 514–4202 or svanek@bop.gov. SUPPLEMENTARY INFORMATION: The overall policy and operations of the NIC are under the supervision of the Board. In general, the NIC provides training, technical assistance, information services, and policy/program development assistance to Federal, state, and local corrections agencies; through cooperative agreements, awards funds to support program initiatives; and provides leadership to influence correctional policies, practices, and operations nationwide in areas of emerging interest and concern to correctional executives and SUMMARY: PO 00000 Frm 00088 Fmt 4703 Sfmt 4703 55989 practitioners as well as public policymakers. The Board will help develop long-range plans, advise on program development, and recommend guidance to assist the NIC’s efforts in these areas. The Board will also advise the Attorney General about the appointment of the Director of the NIC. The Board shall report to the Director of the NIC. The Director of NIC or his/ her designated representatives may act upon the Board’s advice and recommendations. Under 18 U.S.C. 4351(b) and (c), the Board shall consist of sixteen members. The following six individuals shall serve as members of the Board ex officio: The Director of the Federal Bureau of Prisons or his designee, the Director of the Bureau of Justice Assistance or his designee, the Chairman of the United States Sentencing Commission or his designee, the Director of the Federal Judicial Center or his designee, the Administrator for the Office of Juvenile Justice and Delinquency Prevention or his designee, and the Assistant Secretary for Human Development of the Department of Health and Human Services or his designee. The remaining ten members of the Board shall be selected by the Attorney General of the United States, after consultation with the Federal Bureau of Prisons and the NIC. Five of these shall be qualified as a practitioner (Federal, State, or local) in the field of corrections, probation, or parole, and shall serve for staggered three-year terms. Five of these members shall be from the private sector, such as business, labor, and education, having demonstrated an active interest in corrections, probation, or parole, and shall serve for staggered three-year terms. The NIC, when necessary, and consistent with the Board’s mission and NIC policies and procedures may establish subcommittees, task groups, or working groups deemed necessary to support the Board. Establishment of subcommittees will be based upon an identified and articulated need, a verbal or written vote by the Board, and approval by the NIC Director. The Board has established no permanent subcommittees. Any established subcommittees shall not work independently of the chartered Board, and shall report all of their recommendations and advice to the Board for full deliberation and discussion. Subcommittees have no authority to make decisions on behalf of the chartered Board; nor can any subcommittees or any of its members update or report directly to the NIC or any Federal officers or employees. All E:\FR\FM\18OCN1.SGM 18OCN1

Agencies

[Federal Register Volume 84, Number 202 (Friday, October 18, 2019)]
[Notices]
[Pages 55988-55989]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-22727]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Office of Justice Programs

[OJP (NIJ) Docket No. 1768]


Roadside Impairment Detection and Field Sobriety Testing 
Technologies Market Survey

AGENCY: National Institute of Justice (NIJ), Justice.

ACTION: Notice of request for information.

-----------------------------------------------------------------------

SUMMARY: The National Institute of Justice (NIJ) is soliciting 
information for use in an upcoming Criminal Justice Testing and 
Evaluation Consortium (CJTEC) report tentatively titled, ``A Landscape 
Report of Roadside Impairment Detection and Field Sobriety Testing 
Technologies.'' The report will identify technologies that are 
commercially available or near-market technologies to determine 
impairment of an individual in a field setting. This document will 
assist law enforcement agencies in making informed decisions for 
purchasing impairment technologies to determine whether an individual 
is driving while impaired or under the influence of drugs.

DATES: Emailed responses must be received (and mailed responses 
postmarked) by 5:00 p.m. Eastern Time on December 2, 2019.

ADDRESSES: Responses to this request may be submitted electronically by 
email to Marjorie Baldi at [email protected] with the subject line 
``Impairment Detection Technologies Federal Register Response.'' 
Responses may also be sent by mail to the following address: Criminal 
Justice Testing and Evaluation Consortium (CJTEC), ATTN: Marjorie 
Baldi, Impairment Detection Technologies Federal Register Response, RTI 
International, P.O. Box 12194, 3040 E Cornwallis Road, Research 
Triangle Park, NC 27709-2194.

FOR FURTHER INFORMATION CONTACT:  For more information on this market 
survey, please contact Rebecca Shute (CJTEC) by telephone at 919-248-
4218 or [email protected]. For more information on the NIJ CJTEC, visit 
https://nij.ojp.gov/funding/awards/2018-75-cx-k003 and view the 
description, or contact Steven Schuetz (NIJ) by telephone at 202-514-
7663 or at [email protected]. Please note that these are not 
toll-free telephone numbers.

SUPPLEMENTARY INFORMATION: 
    Information sought: Specific product and company information for: 
(1) Technologies that can help law enforcement officers determine that 
a certain level of intoxicant is present in an individual's system at a 
specific cutoff concentration, and (2) technologies that help law 
enforcement officers establish whether an individual is impaired, 
including eye tracking technologies, physical coordination sensors and 
apps, and mental agility apps. An independent response should be 
submitted for each product that respondents would like CJTEC to 
consider in their landscape report. NIJ encourages respondents to 
provide information in common file formats, such as Microsoft Word, 
pdf, or plain text. Each response should include contact information.
    Usage: Information provided in response to this request may be 
published in the upcoming landscape report, ``A Landscape Study of 
Roadside Impairment Detection and Field Sobriety Testing 
Technologies.''
    Information categories: Comments are invited with regard to the 
market survey, including which categories of information are 
appropriate for comparison, as well as promotional material (e.g., 
slick sheet) and print-quality photographs of the technology. At a 
minimum, CJTEC intends to include the following categories of 
information for each technology that may be of use to law enforcement 
officials:

1. Vendor Information
    a. Full name of company
    b. Contact information for technical contact for products
    c. Website URL
    d. Years the company has been in business
    e. Number and types of customers served (e.g., municipal, county, 
or state agencies)
    f. Location where the technologies are manufactured, assembled, 
refurbished
    g. Picture or photograph of product
    h. Vendor logo
2. Product Information
    a. Device Category
    i. Technologies that determine that a certain level of intoxicant 
is present in an individual's system at a specific cutoff concentration 
(this includes products that detect the presence of drugs in breath, 
oral fluid, sweat or other matrices)
    ii. Technologies that establish whether an individual is impaired, 
including eye tracking technologies, physical coordination sensors and 
apps, and mental agility apps.
    b. Physical Information
    i. Dimensions (in inches)
    ii. Weight (in pounds)
    iii. Primary materials used to construct the product

[[Page 55989]]

    iv. Temperature range in which the product can reliably operate (in 
Fahrenheit and Celsius)
    v. Display unit (e.g., diagonal size of screen in inches as well as 
type of screen)
    vi. Ruggedization (including features that optimize the product for 
field use, such as waterproofing, and any corresponding standards 
compliance)
    c. Technical Specifications
    i. Type of sensor or test used to determine impairment or 
intoxication
    ii. Detection range of sensor or test (e.g., g/L)
    iii. Cut-off concentration for each drug tested (ng/mL)
    iv. Accuracy of the instrument (e.g., standard error, false 
positive and false negative rate)
    v. Memory capability of instrument (either in MB/GB or number of 
tests stored)
    vi. Whether test records and other data on the instrument can be 
transferred, and the method by which it is transferred (e.g., internet 
connectivity, ethernet cables, Bluetooth connectivity)
    vii. Power supply (e.g. battery or voltage of power supply)
    viii. Battery life, if applicable
    ix. Standard accessories offered
    d. Types/Classes of Drugs Detected
    i. Alcohol
    ii. Opioids
    iii. Benzodiazepines
    iv. Cannabinoids
    v. Barbiturates
    vi. Cocaine
    vii. Amphetamines
    viii. Methamphetamines
    ix. Ketamine
    x. Other
    e. Operating Information of Device/Hardware
    i. Calibration requirements for device, if applicable (e.g., how it 
is calibrated, how long it takes, frequency of calibration)
    ii. Average response time of test (in minutes)
    iii. Warm-up time of device (in minutes)
    iv. Training offered and cost
    v. Technical support offered and cost
    vi. Other maintenance required for instrument
    vii. Terms and cost of any standard and/or extended warranties 
offered
    f. Software (if applicable)
    i. Frequency of software updates
    ii. Last known software release date
    iii. Steps needed to update software
    iv. Operating System required for use
    v. Other system requirements for use (e.g., hardware requirements 
or supporting software packages)
    vi. Use of web servers or cloud storage by software
    vii. Licenses required to use the software
    g. Financial Information
    i. Base unit cost (in USD)
    ii. Software costs (including whether it is a subscription service, 
license, or other, in USD)
    iii. Other associated costs (in USD)
    iv. Accessory Costs (in USD)
    v. Training Costs (in USD)
    vi. Financing Options (e.g., lease versus ownership)
    h. Other information
3. Use Cases
    a. Approximate number of units sold to law enforcement (if 
available)
    b. Names and contact information (phone and email) for end users 
who have implemented the product in casework (if available)

David B. Muhlhausen,
Director, National Institute of Justice.
[FR Doc. 2019-22727 Filed 10-17-19; 8:45 am]
 BILLING CODE 4410-18-P